Take the Chance
How to Become a UICC President
PATINA: Major FDA–EMA Divide Over Palbociclib in HER2+ Breast Cancer
Follicular Lymphoma: EHA 2026 Guidelines Move Chemotherapy-Free Combinations to First Relapse
The Promise on Hold: Takeda and Pfizer still to respond to help a Nigerian child with Hodgkin Lymphoma
ALICE Trial at IGCS 2026: Reduced Surgical Morbidity in Endometrial Cancer Staging
What’s New On Radiotherapy of Lung Cancer in 2026?
PharmaMar as a Foundational Partner of OncoDaily Grand Rounds at ESMO 2026: Sarcoma Edition
The ESMO Young Oncologists Committee (YOC) will host the next session of the YO4YO Virtual Session Series on Monday, February 9, 2026, from 14:00 to 15:00 CET. This interactive Clinical […]
The Real World Data and Digital Oncology webinar, EBAI Framework: Evaluating AI-Based Biomarkers in Oncology 2026, is a virtual event that focuses on the practical application of the ESMO Basic […]
The 1st Best of ESMO Levant is scheduled to take place on February 12–13, 2026, in Sulaymaniyah, Iraq. Organized by the Iraqi Society of Clinical Oncology (ISCO) in collaboration with […]
ESMO Therapeutic Landscapes: Toxicity of Multispecific Antibodies and Immune-Cell Engagers 2026 is a specialized technical webinar scheduled for February 18, 2026, focused on the safety profiles and clinical management of […]
The ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano is a two-day educational course focusing on the management of metastatic bladder and kidney cancer, providing oncologists with a […]
The ESMO Guidelines: Real World Cases - Webinar Series: Gastroesophageal Cancer 2026 is a virtual event designed to help medical professionals apply the latest ESMO Clinical Practice Guidelines to the […]
The ESMO Deep Dive: Genitourinary Cancers: Beyond Cure: Optimizing Medical Care in Metastatic Bladder Cancer 2026 is a specialized scientific webinar designed to provide an in-depth clinical analysis of the […]
The ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing, Selecting, Treating 2026: Zurich is a two-day course for experienced oncologists and specialists, focusing […]
The ESMO Advanced Course on Management of Patients with Localised Bladder Cancer: State-of-the-Art Therapeutic Strategies and Ongoing Research 2026: Zurich is an intensive educational program designed to provide medical oncologists […]
The ESMO - The Christie Preceptorship on Lung Cancer 2026: Manchester will be held from March 11-13, 2026, in Manchester, United Kingdom. The application deadline is January 21, 2026, at […]
The ESMO Sarcoma and Rare Cancers Congress 2026 will take place from 12–14 March in Lugano, Switzerland, offering a premier platform for experts to share cutting-edge research and innovative treatment […]
The ESMO Targeted Anticancer Therapies (TAT) Congress 2026 is a major scientific forum organized by the European Society for Medical Oncology (ESMO), focused on accelerating the delivery of life-changing anticancer […]
The ICHNO 2026, the 10th International Congress on Innovative Approaches in Head and Neck Oncology, will be held from 19–21 March 2026 in Seville, Spain, under the theme: “Driven by […]
The ESMO Guidelines: Real World Cases - Webinar Series: Endometrial Cancer 2026 is a specialized virtual scientific meeting scheduled for March 25, 2026, focused on the practical application of clinical practice guidelines in the management of endometrial cancer. Chaired by Ana Oaknin, the webinar features a multidisciplinary panel of experts who discuss the diagnosis, staging, […]
The European Lung Cancer Congress (ELCC 2026) will take place from 25–28 March 2026 in Copenhagen, Denmark, bringing together leading multidisciplinary societies dedicated to thoracic oncology. This congress serves as a key platform for advancing science, sharing education, and enhancing lung cancer care practices globally. With a comprehensive programme designed for medical oncologists, radiation oncologists, […]
The ESMO Advanced Course on the Evolving Role of CDK4/6 Inhibitors in Hormone Receptor Positive HER2 Negative Early and Advanced Breast Cancer 2026: Beijing is an intensive educational symposium scheduled for March 27–28, 2026, in Beijing, China. Co-chaired by Giuseppe Curigliano and Binghe Xu, this 1.5-day course is specifically designed for experienced oncologists and oncology […]
